JP2004534781A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534781A5
JP2004534781A5 JP2003501440A JP2003501440A JP2004534781A5 JP 2004534781 A5 JP2004534781 A5 JP 2004534781A5 JP 2003501440 A JP2003501440 A JP 2003501440A JP 2003501440 A JP2003501440 A JP 2003501440A JP 2004534781 A5 JP2004534781 A5 JP 2004534781A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
conr
aryl
ocon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003501440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534781A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/016842 external-priority patent/WO2002098400A1/en
Publication of JP2004534781A publication Critical patent/JP2004534781A/ja
Publication of JP2004534781A5 publication Critical patent/JP2004534781A5/ja
Pending legal-status Critical Current

Links

JP2003501440A 2001-06-01 2002-05-30 新規なアリールアミノプロパン類似体および緑内障治療へのこれらの使用 Pending JP2004534781A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29542601P 2001-06-01 2001-06-01
PCT/US2002/016842 WO2002098400A1 (en) 2001-06-01 2002-05-30 Novel arylaminopropane analogues and their use for the treatment of glaucoma

Publications (2)

Publication Number Publication Date
JP2004534781A JP2004534781A (ja) 2004-11-18
JP2004534781A5 true JP2004534781A5 (enExample) 2005-12-22

Family

ID=23137665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003501440A Pending JP2004534781A (ja) 2001-06-01 2002-05-30 新規なアリールアミノプロパン類似体および緑内障治療へのこれらの使用

Country Status (10)

Country Link
US (1) US7071225B2 (enExample)
EP (1) EP1392269A1 (enExample)
JP (1) JP2004534781A (enExample)
CN (1) CN1512879A (enExample)
AR (1) AR036076A1 (enExample)
AU (1) AU2002259312B2 (enExample)
BR (1) BR0210238A (enExample)
CA (1) CA2447479A1 (enExample)
MX (1) MXPA03010806A (enExample)
WO (1) WO2002098400A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
US20060106106A1 (en) * 2002-09-24 2006-05-18 Glennon Richard A Beta-hydroxyphenylalkylamines and their use for treating glaucoma
BR0316775A (pt) 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
AR046890A1 (es) 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
EP3371181A4 (en) * 2015-10-18 2019-10-16 Onco Therapies LLC COMPOSITIONS AND METHODS FOR REGULATING DISORDERS AND DISEASES ASSOCIATED WITH CANCER
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
US5151444B1 (en) * 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
DE68929435T2 (de) * 1988-09-06 2003-07-17 Pharmacia Ab, Stockholm Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
WO1992020338A1 (en) 1991-05-10 1992-11-26 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
AU1928892A (en) * 1991-06-21 1993-01-25 Smithkline Beecham Plc Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5922773A (en) 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
TW270114B (enExample) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5874477A (en) * 1994-08-12 1999-02-23 The University Of Hawaii Method of treatment for malaria utilizing serotonin receptor ligands
US5998467A (en) 1995-10-25 1999-12-07 Mitsubishi Chemical Corporation Medicine for oculopathy
AU2104097A (en) 1996-03-13 1997-10-01 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
US5902815A (en) * 1996-09-03 1999-05-11 Washington University Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
WO1998018458A1 (en) 1996-10-31 1998-05-07 Alcon Laboratories, Inc. Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
GB9700899D0 (en) 1997-01-17 1997-03-05 Smithkline Beecham Plc Novel treatment
GB9819033D0 (en) 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
GB9819035D0 (en) 1998-09-01 1998-10-28 Cerebrus Res Ltd Chemical compounds VII
AU755119B2 (en) 1998-09-18 2002-12-05 Alcon Laboratories, Inc. Serotonergic 5HT2 agonists for treating glaucoma
HUP0104773A3 (en) 1998-12-17 2004-10-28 Wyeth Corp 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)quinoxalin-5(6h)one derivates being 5ht2c agonists, process for their preparation and medicaments containing them
GB9902047D0 (en) 1999-01-29 1999-03-17 Cerebrus Ltd Chemical compounds XI
US6713471B1 (en) * 1999-06-15 2004-03-30 Bristol-Myers Squibb Pharma Company Substituted heterocycle fused gamma-carbolines
WO2000077001A1 (en) * 1999-06-15 2000-12-21 Du Pont Pharmaceuticals Company Substituted heterocycle fused gamma-carbolines

Similar Documents

Publication Publication Date Title
JP2023523130A5 (enExample)
RU2219167C2 (ru) N-замещенные аминотетралины как лиганды для рецептора y5 нейропептида y, полезные при лечении ожирения и других расстройств
RU2448101C2 (ru) 5-замещенные изоиндолиновые соединения
JP2005511699A5 (enExample)
CN101952272B (zh) 6-、7-或8-取代的喹唑啉酮衍生物、含有它的组合物及其使用方法
TWI323659B (en) Novel thiazolidin-4-one derivatives
JP2009536660A5 (enExample)
CN101679380A (zh) 4’-o-取代的异吲哚啉衍生物和包含它的组合物及使用方法
JP2011524422A5 (enExample)
CA2686545A1 (en) Deuterated morpholinyl compounds
NO20033145L (no) Purinderivater som purinergiske reseptorantagonister
JP2006511587A5 (enExample)
JP2004531544A5 (enExample)
CN101141960A (zh) 使用4-氨基-2-(3-甲基-2,6-二氧代哌啶-3-基)-异吲哚-1,3-二酮的方法和组合物
JP2006524222A5 (enExample)
JP2005519083A5 (enExample)
JP2006507220A5 (enExample)
JP2006504766A5 (enExample)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2023002701A5 (enExample)
JP2005506298A5 (enExample)
JP2005530811A5 (enExample)
WO2022060812A1 (en) Substituted pyridine derivatives as sarm1 inhibitors
KR930702288A (ko) 타이졸리딘디온 유도체
JPWO2023195529A5 (enExample)